$HEPA Hepion Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Hepion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Hepion Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Hepion Pharmaceuticals, Inc. for free.
IRS Number: 462783806
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: HEPA
Company Address: 399 THORNALL STREET FIRST FLOOR EDISON 08837
Phone number: 732-902-4000
Former name: ContraVir Pharmaceuticals, Inc., date of change: 2013-08-06
Market Capitalization: $85.72M
Prev close: $1.40
Average Daily Volume: 605,803
Days Low: $1.38
Year Low: $0.81
Year High: $2.65
Hepion Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20 2021 | HEPA | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 1.70 | 250,000 | 425,000 | 342,785 | |
| Feb 18 2021 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Buy | P | 2.20 | 10,000 | 22,000 | 30,000 | 20 K to 30 K (+50.00 %) |
| Feb 18 2021 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 2.00 | 20,000 | 40,000 | 45,259 | 25.3 K to 45.3 K (+79.18 %) |
| Dec 21 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Buy | P | 1.91 | 20,000 | 38,200 | 20,000 | 0 to 20 K |
| Dec 08 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 1.58 | 25,000 | 39,418 | 25,259 | 259 to 25.3 K (+9,652.51 %) |
| Nov 30 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Buy | P | 1.62 | 4,500 | 7,290 | 4,800 | 300 to 4.8 K (+1,500.00 %) |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO,CSO and Directo ... | Option Exercise | A | 3.72 | 212,000 | 788,640 | 601,879 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,110 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Block Timothy M. | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,276 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,050 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,332 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 92,785 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 60,000 | |
| Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 3.72 | 160,000 | 595,200 | 381,060 | |
| Jun 25 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Option Exercise | A | 2.73 | 30,000 | 81,900 | 30,000 |